REYON Pharmaceutical (representative directors Sunok Jeong and Yonghwan Yoo) announced on the 17th that it obtained ISO 37001 certification from the Korea Compliance Certification Institute to strengthen ethical management and held a certification presentation ceremony at the head office in Daechi-dong.

The certification presentation ceremony was attended by Yonghwan Yoo, CEO of REYON Pharmaceutical, and Weongi Lee, director of the Korea Compliance Certification Agency, as well as officials from both sides.

ISO 37001 is an international standard that stipulates policies for controlling and preventing corruption risks that may occur across all organizational activities, and is a global standard certification system for the establishment, implementation, maintenance and improvement of an organizational anti-corruption management system.

Starting with the introduction of certification in the first half of this year, REYON Pharmaceutical trains internal auditors, approves corruption policies by holding board meetings, propagates the anti-corruption declaration of the CEO, performs inspections and reviews for corporate-wide corruption risks conducted by internal and external auditors, and establishes and improves anti-corruption targets, and company-wide efforts were made to establish the ISO 37001 anti-corruption management system and to strengthen ethics awareness among employees.

By acquiring ISO 37001 certification, REYON Pharmaceutical has established an anti-corruption management system that meets international standards in connection with the existing ethical management system, and based on this, risks to the company's reputation, legal risks, and ethical risks are prevented in advance.

Yonghwan Yoo, CEO of REYON Pharmaceutical, said, "REYON Pharmaceutical, as a 'pharmaceutical company that investigates the principles of life,” has put the highest priority on operating an ethical company based on responsibility and its sense of duty to be trusted by everyone and contribute to the health of patients for the past 60 years.” He added, "Starting with obtaining ISO 37001 certification, we will continue to strengthen compliance and ethical management to further grow as an exemplary pharmaceutical company fulfilling our social responsibilities.”